We are live on ! Find out more
BMO

Beck Mack & Oliver Portfolio holdings

AUM $4.85B
1-Year Est. Return 9.66%
This Fund
S&P 500
This Quarter Est. Return
+13.12%
1 Year Est. Return
+9.66%
3 Year Est. Return
+69.39%
5 Year Est. Return
+96.17%
10 Year Est. Return
+350.87%
AUM
$4.3B
AUM Growth
+$479M
Cap. Flow
-$13.7M
Cap. Flow %
-0.32%
Top 10 Hldgs %
47.06%
Holding
186
New
16
Increased
26
Reduced
83
Closed
3

Top Buys

Rank Stock Value
1
RUSHA icon
Rush Enterprises Class A
RUSHA
+$5.46M
2
FERG icon
Ferguson
FERG
+$3.54M
3
OWL icon
Blue Owl Capital
OWL
+$3.32M
4
FTRE icon
Fortrea Holdings
FTRE
+$3M
5
SCHW
Charles Schwab
SCHW
+$2.76M

Top Sells

Rank Stock Value
1
SHW icon
Sherwin-Williams
SHW
+$7.68M
2
WMS icon
Advanced Drainage Systems
WMS
+$7.19M
3
TEVA icon
Teva Pharmaceuticals
TEVA
+$6.95M
4
MSFT icon
Microsoft
MSFT
+$5.14M
5
MA icon
Mastercard
MA
+$3.07M

Sector Composition

Rank Sector Weight
1 Financials 40.69%
2 Healthcare 13.57%
3 Technology 12.87%
4 Communication Services 7.57%
5 Industrials 7.32%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
GL icon
76
Globe Life
GL
$14B
$2.57M 0.06%
21,125
– –
PFE icon
77
Pfizer
PFE
$143B
$2.53M 0.06%
88,000
-25
-0% -$756
V icon
78
Visa
V
$701B
$2.48M 0.06%
9,536
+1,225
+15% +$302K
GLD icon
79
SPDR Gold Trust
GLD
$131B
$2.38M 0.06%
12,475
-25
-0.2% -$4.58K
DHR icon
80
Danaher
DHR
$138B
$2.26M 0.05%
9,748
-1,840
-16% -$392K
DE icon
81
Deere & Co
DE
$165B
$2.08M 0.05%
5,200
– –
IVV icon
82
iShares Core S&P 500 ETF
IVV
$858B
$2.01M 0.05%
4,217
– –
CVX icon
83
Chevron
CVX
$382B
$1.79M 0.04%
12,006
– –
BAX icon
84
Baxter International
BAX
$12.8B
$1.75M 0.04%
45,296
-16,874
-27% -$597K
SLB icon
85
SLB Ltd
SLB
$72.7B
$1.72M 0.04%
33,000
– –
CVS icon
86
CVS Health
CVS
$135B
$1.68M 0.04%
+21,339
New +$1.52M
BNY
87
Bank of New York Mellon
BNY
$103B
$1.58M 0.04%
30,380
+14,367
+90% +$662K
DOX icon
88
Amdocs
DOX
$6.03B
$1.52M 0.04%
+17,255
New +$1.44M
MTD icon
89
Mettler-Toledo International
MTD
$28.1B
$1.5M 0.04%
1,240
-200
-14% -$216K
KO icon
90
Coca-Cola
KO
$383B
$1.5M 0.03%
25,444
+7,435
+41% +$422K
HES
91
DELISTED
Hess
HES
$1.3M 0.03%
9,000
– –
AMGN icon
92
Amgen
AMGN
$209B
$1.29M 0.03%
+4,479
New +$1.22M
CNI icon
93
Canadian National Railway
CNI
$78.5B
$1.27M 0.03%
10,100
-50
-0.5% -$5.66K
NDSN icon
94
Nordson
NDSN
$16.4B
$1.27M 0.03%
4,800
– –
VOO icon
95
Vanguard S&P 500 ETF
VOO
$956B
$1.25M 0.03%
2,861
-21
-0.7% -$8.6K
IDXX icon
96
Idexx Laboratories
IDXX
$44.9B
$1.18M 0.03%
2,125
– –
EW icon
97
Edwards Lifesciences
EW
$49.4B
$1.15M 0.03%
15,120
– –
GE icon
98
GE Aerospace
GE
$364B
$1.06M 0.02%
10,384
-501
-5% -$46.4K
PEG icon
99
Public Service Enterprise Group
PEG
$38.7B
$1M 0.02%
16,400
– –
NEE icon
100
NextEra Energy
NEE
$184B
$992K 0.02%
16,338
– –
2 3
4
5 6

Similar funds

SCA
Southpoint Capital Advisors New York $4.86B AUM 34.09% 1-Year Est. Return
MCCA
Mill Creek Capital Advisors Conshohocken, Pennsylvania $4.87B AUM 17.69% 1-Year Est. Return
AC
Aristeia Capital Greenwich, Connecticut $4.82B AUM 24.94% 1-Year Est. Return
TPCW
TD Private Client Wealth New York $4.82B AUM 15.21% 1-Year Est. Return
DGI
Disciplined Growth Investors Minneapolis, Minnesota $4.89B AUM 33.85% 1-Year Est. Return
JSTA
Japan Science & Technology Agency Tokyo, Japan $4.81B AUM 4.62% 1-Year Est. Return
PBA
Paradigm Biocapital Advisors New York $4.89B AUM 251.12% 1-Year Est. Return
KCM
Kensico Capital Management Greenwich, Connecticut $4.9B AUM 41.26% 1-Year Est. Return

Beck Mack & Oliver's Q4 2023 Portfolio in Review

As of Q4 2023, Beck Mack & Oliver held 186 positions worth $4.3B, up 13% from $3.82B the previous quarter. Its ten largest holdings account for 47% of the portfolio.

Beck Mack & Oliver's Q4 2023 filing shows 16 new, 26 increased, 83 reduced and 3 closed positions. Its largest new stake was CVS Health: 21,339 shares worth $1.68M. The largest sale was Sherwin-Williams, an estimated $7.68M.

By sector, the portfolio is most concentrated in Financials at 41% of assets, up from 41% a quarter earlier, followed by Healthcare and Technology.

  • Beck Mack & Oliver's largest Q4 2023 buy was CVS Health: 21,339 shares worth $1.68M.
  • Beck Mack & Oliver added most to Rush Enterprises Class A in Q4 2023, an estimated $5.46M increase.
  • Beck Mack & Oliver's biggest Q4 2023 reduction was Sherwin-Williams, cutting an estimated $7.68M.
  • Beck Mack & Oliver fully exited General Mills in Q4 2023, selling an estimated $384K.
  • Beck Mack & Oliver's ten largest holdings make up 47% of its $4.3B portfolio in Q4 2023.
  • Beck Mack & Oliver opened 16 new positions and closed 3 in Q4 2023.
  • Beck Mack & Oliver's portfolio value rose 13% quarter-over-quarter to $4.3B.

Based on Beck Mack & Oliver's 13F filing for Q4 2023, filed 14 Feb 2024.